
Understanding Medetomidine: Emerging Challenges for Addiction Medicine
Episode 23
In the Season 2 premiere of ASAM Practice Pearls, Drs. Stephen Taylor and Jeanmarie Perrone follow up on Season 1’s episode, Emerging Illicit Substances: What Clinicians Need to Know. Together, they discuss how medetomidine has continued to spread to different regions and what has changed over the past year. They explore strategies for managing medetomidine withdrawal, keeping patients safe, and preparing for this growing public health threat. ----more---- Looking for this episode's transcript? Download it HERE Get credit for listening! Claim your 0.5 CEs HERE Have an idea for a future episode? Share it with us at education@asam.org. Host Stephen M. Taylor, MD, MPH, DFAPA, DFASAM Dr. Stephen M. Taylor is ASAM's President and is board-certified in general psychiatry, child and adolescent psychiatry, addiction psychiatry, and addiction medicine. With over 30 years of practice experience, Dr. Taylor is dedicated to helping adolescents and adults overcome addiction and co-occurring psychiatric disorders. He has served as the Medical Director of the NBA and NBPA Player Assistance and Anti-Drug Program for 16 years and is the Chief Medical Officer of Pathway Healthcare, which operates multiple outpatient addiction and mental health treatment offices across six states. Expert Jeanmarie Perrone, MD, FASAM, FACMT Dr.
Publisher
ASAM Practice Pearls
Link
asampracticepearls.podbean.com/e/understanding-medetomidine-emerging-challenges-for-addiction%e2%80%afmedicine/
Published
February 9, 2026
Duration
21 min
Format
Podcast
Category
Lifestyle · Medicine
Source
RSS feed
Host
ASAM Education
ASAM Practice Pearls
@asampracticepearls
#understandingmedetomidine #emergingchallenges #addictionmedicine #medicine
